Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telmisartan in haemodialysis patients with hypertension and endothelial dysfunction
2005-005021-60Phase 3Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of telmisartan in hypertension (HTN) and endothelial dysfunction (2 arms), sponsored by Charité – Universitätsmedizin Berlin. Primary endpoint: Efficacy and safety of telmisartan in haemodialysis patients. Started Dec 2006; status: completed.
02
Drugs
telmisartan
03
Conditions
hypertension (HTN)endothelial dysfunction
Beyond the preview
Go deeper on 2005-005021-60.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005021-60.